Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the worldᅢᄁ¬ツᆲ¬トᄁs largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+ᅢツᅡᆴ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. Learn more at www.helix.com.